The BMS Kidney Transplant Co-Pay Assistance Program offers financial assistance to eligible, commercially insured patients. The program provides financial assistance with the out-of-pocket deductibles, co-pay, or co-insurance costs for eligible patients who have been prescribed a BMS kidney transplant medication.

Program at a Glance:

Enrolled patients pay the first $50 of their co-pay for each outpatient dose.

BMS will cover the remaining amount up to $7,000 per year per product per enrollment term (12 months).

Restrictions apply. Final determination of Program eligibility is based upon review of completed application. Please click here for full Terms and Conditions, including complete eligibility requirements.

Please note: The Program will cover the out-of-pocket expenses of the BMS product only. It does not cover the costs of any other healthcare provider charges or any other treatment costs. Patients may be responsible for non-drug-related out-of-pocket costs, depending on their specific healthcare benefits.

How Does It Work? It's Simple.

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.